<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ATAI
Atai Life Sciences
$
()


  • Rising High: Exclusive talk with cannabis market research firm BDSA

    4/18/2024 - 11:35am
  • Atai Life announces publication of Beckley Psytech's Phase 1 study of BPL-003

    4/17/2024 - 07:05am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    4/11/2024 - 10:24am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    4/4/2024 - 11:06am
  • What You Missed On Wall Street This Morning

    4/3/2024 - 12:19pm
  • Maxim upgrades Atai to Buy amid renewed psychedelic interest

    4/3/2024 - 09:24am
  • Maxim gets more bullish on Atai Life Sciences, upgrades shares

    4/3/2024 - 07:48am
  • Atai Life Sciences undervalued with catalysts ahead, says Canaccord

    4/3/2024 - 06:59am
  • Atai Life Sciences price target lowered by $5 at H.C. Wainwright, here's why

    4/3/2024 - 06:09am
  • Rising High: Exclusive talk with financial services firm Safe Harbor Financial

    3/28/2024 - 11:32am
  • Fly Intel: Pre-market Movers

    3/28/2024 - 08:59am
  • Atai Life Sciences sees cash runway into 2026

    3/28/2024 - 07:11am
  • Atai Life Sciences reports Q4 EPS (12c), consensus (16c)

    3/28/2024 - 07:10am
  • Atai Life announces initial results from Psytech's Phase 2a study of BPL-003

    3/27/2024 - 07:12am
  • Here's What You Missed in Cannabis, Psychedelics This Week

    3/21/2024 - 10:52am
dynamic_feed Breaking News